Swan Genomics
PrivateLast Round
Grant
Mar 5, 2026
Total Funding Raised
$5.77M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Swan Genomics operates in Healthcare & Life Sciences and is based in Sydney. Its latest recorded funding round was a Grant round in March 2026.
Swan Genomics is a biotechnology company that is developing a novel single-molecule DNA sequencing platform intended to make genomics data more accessible, scalable, and affordable.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Precision Medicine
Business Model
B2B
Customer Profile
Usage-Based SaaS, Hardware Sales, Hardware + Subscription
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Swan Genomics Comparables
Compare Swan Genomics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Pacific Biosciences of California, Inc. | 74% | |
| Oxford Nanopore Technologies | 72% | |
| Element Biosciences | 72% |
For institutional investors. Book with your work email.
Swan Genomics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 5, 2026 | ||||
| Grant | Mar 10, 2025 | ||||
| Pre Seed | Sep 1, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Swan Genomics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Investible | Pre Seed |
| NSW Government | Grant |
| Proto Axiom | Pre Seed |
| In-Q-Tel | Pre Seed |
| Pacific Channel | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 29, 2026
Monthly visitors increased 1355% MoM, reaching 1.7K.
- Mar 5, 2026
$320K raised from NSW Government
For institutional investors. Book with your work email.
Swan Genomics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Swan Genomics's valuation, stock price, and market status.
Is Swan Genomics a public or private company?
Swan Genomics is a private company.
What is the current stock price of Swan Genomics?
Swan Genomics is a private company, so its shares have no public market price. Caplight tracks Swan Genomics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Swan Genomics worth (valuation)?
Valuation information for Swan Genomics is not publicly available.
Can I buy Swan Genomics stock?
Swan Genomics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Swan Genomics's last funding round?
Swan Genomics's most recent funding round was Grant on March 5, 2026.
Who are the main investors in Swan Genomics?
Key investors in Swan Genomics include Proto Axiom.
Will Swan Genomics IPO soon?
No public IPO plans have been announced for Swan Genomics.
How can I track Swan Genomics secondary market activity?
Caplight tracks bids, offers, and trades in Swan Genomics's shares on secondary markets.